Vertaling van "practice in nuclear medicine " (Nederlands → Frans) :

- Bacher K, Thierens H.M.: Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine; Nucl Med Communications, 2005; 26:591-586
- Bacher K, Thierens H.M. : Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine; Nucl Med Communications, 2005; 26:591-586

- Otte A, Dierckx R.A.: Good clinical practice: a plea for nuclear medicine; Nucl Med Communications, 2005; 26:261
- Otte A, Dierckx R.A. : Good clinical practice : a plea for nuclear medicine; Nucl Med Communications, 2005; 26:261

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

- Corrao S, Arnone G, Arnone S, Baldari S: Medical ethics, clinical research, and special aspects in nuclear medicine; Q J Nucl Med Mol Im, 2004; 448(3): 175-80
- Corrao S, Arnone G, Arnone S, Baldari S : Medical ethics, clinical research, and special aspects in nuclear medicine; Q J Nucl Med Mol Im, 2004; 48:175-80

- Huda W, Scimger JW: Irradiation of volunteers in nuclear medicine; J Nucl Med, 1989; 30(2): 260-4
- Huda W, Scimger JW : Irradiation of volunteers in nuclear medicine ; J Nucl Med, 1989; 30:260-4

Guidelines for the Reference Administered Activities approved by the working group of the Belgian Society for Nuclear Medicine
Guidelines for the Reference Administered Activities approved by the working group of the Belgian Society for Nuclear Medecine

2] ICRU, International Commission on Radiation Units and Measurements, Absorbeddose specification in nuclear medicine, ICRU Report 67, 7910 Woodmont Avenue, Suite 800, Bethesda Maryland 20814-3095, 2002.
2] ICRU, International Commission on Radiation Units and Measurements, Absorbed-dose specification in nuclear medicine, ICRU Report 67, 7910 Woodmont Avenue, Suite 800, Bethesda Maryland 20814-3095, 2002.

Centre Hospitalier Universitaire, Division of Nuclear Medicine, Sart Tilman B35, 4000 Liège toegekend bedrag: € 242 500, verdeeld over 4 jaar
Centre Hospitalier Universitaire, Division of Nuclear Medicine, Sart Tilman B35, 4000 Liège Montant octroyé: € 242 500, répartis sur 4 ans

Protection of the patient in nuclear medicine.
Protection of the patient in nuclear medecine.

The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.
The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.